account_id none on file
legal_name Incyte Corp
ticker INCY
cik 879169
domain incyte.com
linkedin_company_url https://www.linkedin.com/company/incyte/
entry_point_account_id none on file
name Incyte Corp.
exchange Nasdaq
sector Health Care
hq Wilmington, DE, United States
sector index/company/sector/health-care/
calls 1 filings 0 executives 1 family 0
why_nownone on file
calls
While for Opsalura we will not be providing full-year guidance at this point, in the first quarter we expect to see again the effect of typical Q1 dynamics on net sales, including higher patient out-of-pocket costs due to the plan deductibles resetting at the beginning of the year, and the impact of holidays, medical conferences, and other events on dermatology product sales.
Feb 13, 2024 / receipt, needs a key / Pablo, CEO | earnings call 2024-02-13 | transcript c3ea2143-5468-41fc-9667-2a60145c5e3f | chars 23393-23771 | segment 23
filingsnone on file
executives
| Thomas Tray | Vice President | - | receipt |
familynone on file
upcoming
| 2026-10-27 | earnings call | scheduled | ir |
changes
| 2022-01-14 | Vice President, appointed | sec_8k |
mcp_package_hint
slug incyte-corp
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$